Back

Utility of mineralocorticoid receptor antagonists in reducing burden of atrial fibrillation

European Heart Journal

17 October 2024
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CARDIOVASCULAR PHARMACOLOGY Atrial Fibrillation (AF) PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Thalys Sampaio Rodrigues
Thalys Sampaio Rodrigues

Author

Prashanthan Sanders
Prashanthan Sanders

Author

University of Adelaide Adelaide , Australia

Han S Lim
Han S Lim

Author

Austin and Northern Health, University of Melbourne Melbourne , Australia

You may be interested in
thumbnail
Congress Presentation
The mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction
29 June 2021
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025
thumbnail
Congress Presentation
Roles of aldosterone on ventricular arrhythmias, and associated gap junction and ion channel remodeling in hypertrophic heart
25 August 2023
thumbnail
Congress Session
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources